Home
About
FAQ
History (4)
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis.
Schilsky M. (eds) Management of Wilson Disease. Clinical Gastroenterology
Stem cell gene manipulation and delivery as systemic therapeutics.
TC-2559, an a4ß2 nicotinic acetylcholine receptor agonist, suppresses the expression of CCL3 and IL-1ß through STAT3 inhibition in cultured murine macrophages.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Stem cell gene manipulation and delivery as systemic therapeutics.
Almeida-Porada GD. Stem cell gene manipulation and delivery as systemic therapeutics. Adv Drug Deliv Rev. 2010 Sep 30; 62(12):1139-40.
View in:
PubMed
subject areas
Genes
Genetic Engineering
Hematopoietic Stem Cells
Humans
Phenotype
Stem Cells
Therapeutics
authors with profiles
M Graca N. Almeida-Porada MD, PhD